Patents Assigned to WUHAN NOVAFFEY SCIENCE & TECHNOLOGY CO., LTD.
  • Publication number: 20180099962
    Abstract: This invention involves the field of biomedicine, and reveals naphthyridine compounds, medical combinations and use thereof. The naphthyridine compounds has the structure as shown by Formula (I), or its stereoisomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or their prodrugs. The naphthyridine compounds of this invention has anti-tumor efficacy significantly superior to that of prior art. Moreover, the naphthyridine compounds of this invention can treat diseases mediated by protein kinases.
    Type: Application
    Filed: January 10, 2017
    Publication date: April 12, 2018
    Applicants: Nanjing Natinefy Pharmatech Co., Ltd., WUHAN NOVAFFEY SCIENCE & TECHNOLOGY CO., LTD.
    Inventor: Wei Huang
  • Patent number: 9938274
    Abstract: This invention involves the field of biomedicine, and reveals naphthyridine compounds, medical combinations and use thereof. The naphthyridine compounds has the structure as shown by Formula (I), or its stereoisomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or their prodrugs. The naphthyridine compounds of this invention has anti-tumor efficacy significantly superior to that of prior art. Moreover, the naphthyridine compounds of this invention can treat diseases mediated by protein kinases.
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: April 10, 2018
    Assignees: NANJING NATINEFY PHARMATECH CO., LTD., WUHAN NOVAFFEY SCIENCE & TECHNOLOGY CO., LTD.
    Inventor: Wei Huang